Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytes.
Parmiani
G
G
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan, Italy.
Fossati
G
G
Radrizzani
M
M
Gambacorti-Passerini
C
C
Marolda
R
R
Cascinelli
N
N
D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology*; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014182:Transplantation, Autologous
D007376:Interleukin-2; D011994:Recombinant Proteins